uterine corpus endometrial carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
colorectal cancer |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
breast cancer |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
gastric adenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
head and neck squamous cell carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
neuroblastoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
multiple myeloma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
lung adenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
brain glioma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
glioblastoma multiforme |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
cervix carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|